Small-sized vessel vasculitis with weight loss: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Created page with "__NOTOC__ {{CMG}}; {{AE}} {{EG}} <span style="font-size:85%">'''Abbreviations:''' ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptid...") |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{EG}} | {{CMG}}; {{AE}} {{EG}} | ||
<span style="font-size:85%">'''Abbreviations:''' | <span style="font-size:85%">'''Abbreviations:''' | ||
ABG= [[Arterial blood gas]], ANA= [[Antinuclear antibody]], ANP= [[Atrial natriuretic peptide]], ASO= [[Antistreptolysin O|Antistreptolysin O antibody]], BNP= [[Brain natriuretic peptide]], CBC= [[Complete blood count]], COPD= [[Chronic obstructive pulmonary disease]], CRP= [[C-reactive protein]], CT= [[Computed tomography]], CXR= [[Chest X-ray]], DVT= [[Deep vein thrombosis]], ESR= [[Erythrocyte sedimentation rate]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]], LDH= [[Lactate dehydrogenase]], PCWP= [[Pulmonary capillary wedge pressure]], PCR= [[Polymerase chain reaction]], PFT= [[Pulmonary function test]].</span> | ABG= [[Arterial blood gas]], ANA= [[Antinuclear antibody]], ANP= [[Atrial natriuretic peptide]], ASO= [[Antistreptolysin O|Antistreptolysin O antibody]], BNP= [[Brain natriuretic peptide]], CBC= [[Complete blood count]], COPD= [[Chronic obstructive pulmonary disease]], CRP= [[C-reactive protein]], CT= [[Computed tomography]], CXR= [[Chest X-ray]], DVT= [[Deep vein thrombosis]], ESR= [[Erythrocyte sedimentation rate]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]], LDH= [[Lactate dehydrogenase]], PCWP= [[Pulmonary capillary wedge pressure]], PCR= [[Polymerase chain reaction]], PFT= [[Pulmonary function test]].</span> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | ||
Line 37: | Line 35: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
|- | |- | ||
! rowspan=" | ! rowspan="30" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]]<ref name="pmid20688249">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C-ANCA|Anti-PR3 antibody (C-ANCA)]] (40%), [[P-ANCA|Anti-MPO antibody (P-ANCA)]] (60%) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normocytic anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Proteinuria]], [[RBC casts|Erythrocyte casts]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Suspected [[pancreatitis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mesenteric]] [[angiography]] for differentiating from [[polyarteritis nodosa]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bilateral nodular, and patchy [[Opacity|opacities]] in [[Chest X-ray|CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Glomerulonephritis]] with focal [[necrosis]], crescent formation, and lack or paucity of [[immunoglobulin]] deposits | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash]], [[Hemoptysis]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]]<ref name="pmid27195187">{{cite journal| author=Kubaisi B, Abu Samra K, Foster CS| title=Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. | journal=Intractable Rare Dis Res | year= 2016 | volume= 5 | issue= 2 | pages= 61-9 | pmid=27195187 | doi=10.5582/irdr.2016.01014 | pmc=4869584 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27195187 }}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]]<ref name="pmid27195187">{{cite journal| author=Kubaisi B, Abu Samra K, Foster CS| title=Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. | journal=Intractable Rare Dis Res | year= 2016 | volume= 5 | issue= 2 | pages= 61-9 | pmid=27195187 | doi=10.5582/irdr.2016.01014 | pmc=4869584 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27195187 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
Line 66: | Line 85: | ||
[[Optic nerve]] vasculitis | [[Optic nerve]] vasculitis | ||
|- | |- | ||
! rowspan=" | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis]] | ||
[[Eosinophilic granulomatosis with polyangiitis|(Churg-Strauss)]]<ref name="pmid16612766">{{cite journal |vauthors=Keogh KA, Specks U |title=Churg-Strauss syndrome |journal=Semin Respir Crit Care Med |volume=27 |issue=2 |pages=148–57 |date=April 2006 |pmid=16612766 |doi=10.1055/s-2006-939518 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[P-ANCA|Anti-MPO antibody (P-ANCA)]] (40%), Eotaxin-3 | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Proteinuria]], [[RBC casts|Erythrocyte casts]], ↑[[Immunoglobulin E|IgE]] levels | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Significant enlargement of peripheral [[pulmonary arteries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Myocardial ischemia]] and [[Myocardial infarction|infarction]] in [[coronary angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Congestive heart failure|Congestive heart failure (CHF)]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Extensive air-space [[Opacity|opacities]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Small [[necrotizing]] [[granulomas]] with [[eosinophilic]] core surrounded by [[macrophages]] and [[Epithelioid cell|epithelioid giant cells]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Allergic rhinitis]], [[Asthma]], [[Urticaria|Urticarial rash]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hydralazine]]-associated [[ANCA-associated vasculitis]]<ref name="pmid23316942">{{cite journal| author=Keasberry J, Frazier J, Isbel NM, Van Eps CL, Oliver K, Mudge DW| title=Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report. | journal=J Med Case Rep | year= 2013 | volume= 7 | issue= | pages= 20 | pmid=23316942 | doi=10.1186/1752-1947-7-20 | pmc=3565908 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23316942 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[P-ANCA|Anti-MPO antibody (P-ANCA)]], Anti-histone antibodies | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Hypoalbuminemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bilateral [[pulmonary]] infiltrates | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Pauci-immune [[necrotizing]] and [[crescentic glomerulonephritis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Sinusitis]], [[Hemoptysis]] | |||
|- | |||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]<ref name="pmid28515156">{{cite journal |vauthors=McAdoo SP, Pusey CD |title=Anti-Glomerular Basement Membrane Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=7 |pages=1162–1172 |date=July 2017 |pmid=28515156 |doi=10.2215/CJN.01380217 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypochromic anemia|Hypochromic microcytic anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C3 (complement)|C3]] level | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal [[kidneys]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Alveolar]] infiltrates spreading from the [[hilum]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Cellular crescents in the [[glomeruli]], [[Pulmonary hemorrhage|Intra-alveolar hemorrhages]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hemoptysis]], [[Hematuria]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]<ref name="pmid16344620">{{cite journal |vauthors=Ferri C, Mascia MT |title=Cryoglobulinemic vasculitis |journal=Curr Opin Rheumatol |volume=18 |issue=1 |pages=54–63 |date=January 2006 |pmid=16344620 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[hypocomplementemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O underlying [[malignancy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bacterial endocarditis]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interstitial]] involvement or [[pleural effusions]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HCV]]-associated [[proteins]] in [[vasculitic]] [[skin]], Intraluminal [[cryoglobulin]] deposits | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acrocyanosis]], [[Retinal]] [[hemorrhage]], [[Purpura]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]<ref name="pmid28810602">{{cite journal| author=Guo QY, Wu M, Wang YW, Sun GD| title=Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. | journal=Exp Ther Med | year= 2017 | volume= 14 | issue= 2 | pages= 1395-1398 | pmid=28810602 | doi=10.3892/etm.2017.4671 | pmc=5525644 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28810602 }}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]<ref name="pmid28810602">{{cite journal| author=Guo QY, Wu M, Wang YW, Sun GD| title=Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. | journal=Exp Ther Med | year= 2017 | volume= 14 | issue= 2 | pages= 1395-1398 | pmid=28810602 | doi=10.3892/etm.2017.4671 | pmc=5525644 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28810602 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
Line 132: | Line 236: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Urticaria]], [[Hematuria]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Urticaria]], [[Hematuria]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute mesenteric ischemia]]<ref name="pmid24267504">{{cite journal |vauthors=Sise MJ |title=Acute mesenteric ischemia |journal=Surg. Clin. North Am. |volume=94 |issue=1 |pages=165–81 |date=February 2014 |pmid=24267504 |doi=10.1016/j.suc.2013.10.012 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FABP1|I-FABP]], [[GSTA1|Alpha-GST]], [[Ischemia-modified albumin (IMA)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], ↑[[Hematocrit|HCT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↑[[Amylase]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bowel]] wall thickening, [[Pneumatosis intestinalis|Intestinal pneumatosis]], [[Mesenteric ischemia|Portomesenteric]] thrombosis | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mesenteric vein thrombosis|Mesenteric venous thrombosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Artery|Arterial]] [[stenosis]] or occlusion of the [[Celiac artery|celiac]] or [[superior mesenteric arteries]] in [[duplex ultrasound]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ileus]] with distended loops of [[bowel]], [[Bowel]] wall thickening in [[abdominal X-ray]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Superficial [[Mucosal bleeding|mucosal hemorrhage]], [[edema]] and [[necrosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Abdominal pain]], [[Distension]], [[Absent bowel sounds]] | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infective Endocarditis]]<ref name="pmid19665088">{{cite journal| author=McDonald JR| title=Acute infective endocarditis. | journal=Infect Dis Clin North Am | year= 2009 | volume= 23 | issue= 3 | pages= 643-64 | pmid=19665088 | doi=10.1016/j.idc.2009.04.013 | pmc=2726828 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19665088 }}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infective Endocarditis]]<ref name="pmid19665088">{{cite journal| author=McDonald JR| title=Acute infective endocarditis. | journal=Infect Dis Clin North Am | year= 2009 | volume= 23 | issue= 3 | pages= 643-64 | pmid=19665088 | doi=10.1016/j.idc.2009.04.013 | pmc=2726828 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19665088 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
Line 154: | Line 280: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Janeway lesions]], [[Osler nodes]], [[Roth's spot|Roth spots]], [[Vertebral osteomyelitis]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Janeway lesions]], [[Osler nodes]], [[Roth's spot|Roth spots]], [[Vertebral osteomyelitis]] | ||
|- | |- | ||
! rowspan=" | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leukocytoclastic vasculitis|Leukocytoclastic Vasculitis]]<ref name="pmid26176572">{{cite journal| author=Einhorn J, Levis JT| title=Dermatologic Diagnosis: Leukocytoclastic Vasculitis. | journal=Perm J | year= 2015 | volume= 19 | issue= 3 | pages= 77-8 | pmid=26176572 | doi=10.7812/TPP/15-001 | pmc=4500485 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26176572 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IgM]], [[IgA]], [[Immunoglobulin G|IgG]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypocomplementemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vascular]] [[stenosis]] and [[obstruction]] in visceral [[Angiogram|angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Perivascular [[inflammatory]] infiltrate of [[neutrophils]] with leukocytoclasia (releasing [[nuclear]] debris) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Purpura|Palpable purpura]], [[Petechiae]] | |||
|- | |||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Langerhans Cell Histiocytosis]]<ref name="pmid18572052">{{cite journal |vauthors=Margo CE, Goldman DR |title=Langerhans cell histiocytosis |journal=Surv Ophthalmol |volume=53 |issue=4 |pages=332–58 |date=2008 |pmid=18572052 |doi=10.1016/j.survophthal.2008.04.007 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CD1a]], CD207,[[BRAF (gene)|BRAF-V600E]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypercalcemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary cystic lymphangiectasis|Pulmonary cysts]] and [[Pulmonary nodule|nodules]], [[Lytic|Bone lytic lesions]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatomegaly]], [[Splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebellum]] and [[pons]] hyperintensity in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Birbeck granules]] by [[electron microscopy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Brown to purplish [[papules]], [[Eczematous Scaling|Eczematous rash]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]<ref name="pmid18452692">{{cite journal| author=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA| title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | journal=Mayo Clin Proc | year= 2008 | volume= 83 | issue= 5 | pages= 584-94 | pmid=18452692 | doi=10.4065/83.5.584 | pmc=2718421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452692 }}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]<ref name="pmid18452692">{{cite journal| author=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA| title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | journal=Mayo Clin Proc | year= 2008 | volume= 83 | issue= 5 | pages= 584-94 | pmid=18452692 | doi=10.4065/83.5.584 | pmc=2718421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452692 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 197: | Line 365: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | ||
|- | |- | ||
! rowspan=" | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary Infarction]]<ref name="pmid15821192">{{cite journal |vauthors=Parambil JG, Savci CD, Tazelaar HD, Ryu JH |title=Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy |journal=Chest |volume=127 |issue=4 |pages=1178–83 |date=April 2005 |pmid=15821192 |doi=10.1378/chest.127.4.1178 |url=}}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[D-dimer]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[leukocytosis]], Mild [[anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypoxemia]], [[Hypocarbia]] or [[Hypercarbia]], [[Respiratory alkalosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary embolism]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low-[[density]] filling defect within the [[pulmonary artery]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pericardial effusion]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary]] infiltrates, [[atelectasis]], and [[pleural effusions]] in [[Chest X-ray|CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Infarct]] induced [[apoptosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary artery]] [[angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute poststreptococcal glomerulonephritis|Acute Poststreptococcal Glomerulonephritis]]<ref name="pmid25554106">{{cite journal |vauthors=VanDeVoorde RG |title=Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis |journal=Pediatr Rev |volume=36 |issue=1 |pages=3–12; quiz 13 |date=January 2015 |pmid=25554106 |doi=10.1542/pir.36-1-3 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antistreptococcal antibodies|Antistreptolysin-O (ASO) titers]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypocomplementemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal to slightly enlarged [[kidneys]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Central venous pressure|Central venous]] congestion in a [[hilar]] pattern in [[Chest X-ray|CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hypercellularity of [[Endothelial cells|endothelial]] and [[mesangial cells]], Infiltration of the [[glomerular]] tuft with [[polymorphonuclear cells]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]] | |||
|- | |||
! rowspan="8" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]<ref name="pmid11691946">{{cite journal |vauthors=Corrigan JJ, Boineau FG |title=Hemolytic-uremic syndrome |journal=Pediatr Rev |volume=22 |issue=11 |pages=365–9 |date=November 2001 |pmid=11691946 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C5a|C5b-9]], [[ADAMTS13]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]], [[Thrombocytopenia]], [[Reticulocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Lactate dehydrogenase|Lactate dehydrogenase (LDH)]], [[Hypercalcemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thalami]], [[brainstem]], or [[cerebellum]] abnormality | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebral]] [[microangiopathy]] or [[hypertension]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hypoechoic [[kidney]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abnormal hyperintensity in the [[Brain|brain cisterns]] in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thromboses|Microthromboses]] include [[Fibrin|fibrin thrombi]] that may occlude the [[glomerular]] tuft | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Proteinuria]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]]<ref name="pmid15561682">{{cite journal |vauthors=Byrd JC, Stilgenbauer S, Flinn IW |title=Chronic lymphocytic leukemia |journal=Hematology Am Soc Hematol Educ Program |volume= |issue= |pages=163–83 |date=2004 |pmid=15561682 |doi=10.1182/asheducation-2004.1.163 |url=}}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]]<ref name="pmid15561682">{{cite journal |vauthors=Byrd JC, Stilgenbauer S, Flinn IW |title=Chronic lymphocytic leukemia |journal=Hematology Am Soc Hematol Educ Program |volume= |issue= |pages=163–83 |date=2004 |pmid=15561682 |doi=10.1182/asheducation-2004.1.163 |url=}}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
Line 239: | Line 471: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Protein electrophoresis]] plus conventional [[X-rays]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Protein electrophoresis]] plus conventional [[X-rays]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Constipation]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Constipation]] | ||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]]<ref name="pmid19630574">{{cite journal |vauthors=Klion A |title=Hypereosinophilic syndrome: current approach to diagnosis and treatment |journal=Annu. Rev. Med. |volume=60 |issue= |pages=293–306 |date=2009 |pmid=19630574 |doi=10.1146/annurev.med.60.062107.090340 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IgE]], [[CD117]] with [[CD2]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑Serum [[tryptase]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphadenopathy]] and [[splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Intracardiac thrombus|Intracardiac thrombi]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Reticulin|Reticulin stain]] for [[myelofibrosis]] and [[tryptase]] staining for [[mast cells]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Splinter hemorrhages]], [[Raynaud phenomenon]] | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]<ref name="pmid22835603">{{cite journal |vauthors=Shankland KR, Armitage JO, Hancock BW |title=Non-Hodgkin lymphoma |journal=Lancet |volume=380 |issue=9844 |pages=848–57 |date=September 2012 |pmid=22835603 |doi=10.1016/S0140-6736(12)60605-9 |url=}}</ref> | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]<ref name="pmid22835603">{{cite journal |vauthors=Shankland KR, Armitage JO, Hancock BW |title=Non-Hodgkin lymphoma |journal=Lancet |volume=380 |issue=9844 |pages=848–57 |date=September 2012 |pmid=22835603 |doi=10.1016/S0140-6736(12)60605-9 |url=}}</ref> | ||
Line 260: | Line 513: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Surgically excised tissue [[biopsy]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Surgically excised tissue [[biopsy]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Testicular mass]], [[Skin lesions|Skin lesion]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Testicular mass]], [[Skin lesions|Skin lesion]] | ||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Serum sickness|Serum Sickness]]<ref name="pmid2867672">{{cite journal |vauthors=Lin RY |title=Serum sickness syndrome |journal=Am Fam Physician |volume=33 |issue=1 |pages=157–62 |date=January 1986 |pmid=2867672 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IL-1]], [[IL-6]], [[TNF]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Gammopathy|Polyclonal gammopathy]], ↑[[Cr]], [[Cryoglobulinemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Arteritic lesions are focal, [[necrotizing]], and [[inflammatory]] involving all layers of the [[artery]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Skin rash]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]]<ref name="pmid25535423">{{cite journal| author=Venugopal A| title=Disseminated intravascular coagulation. | journal=Indian J Anaesth | year= 2014 | volume= 58 | issue= 5 | pages= 603-8 | pmid=25535423 | doi=10.4103/0019-5049.144666 | pmc=4260307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25535423 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fibrin degradation product|Fibrin degradation product (FDP)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]], [[Schistocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[D-dimer]], [[aPTT]] and [[PT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Intracranial hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ischemia]] and [[necrosis]] due to [[Fibrin|fibrin deposition]] in small and medium-sized [[vessels]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Cyanosis|Acral cyanosis]], [[Hemorrhagic]] skin [[Infarction|infarctions]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Idiopathic thrombocytopenic purpura|Idiopathic Thrombocytopenic Purpura]]<ref name="pmid27441004">{{cite journal| author=Nomura S| title=Advances in Diagnosis and Treatments for Immune Thrombocytopenia. | journal=Clin Med Insights Blood Disord | year= 2016 | volume= 9 | issue= | pages= 15-22 | pmid=27441004 | doi=10.4137/CMBD.S39643 | pmc=4948655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27441004 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FCGR2B|FC gamma receptors (FCGR) IIb]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HIV]], [[ANA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O other causes | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O [[splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased number of normal morphologic [[megakaryocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Purpura]] | |||
|- | |- | ||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ||
Line 370: | Line 686: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:30, 10 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Abbreviations: ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptide, ASO= Antistreptolysin O antibody, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure, PCR= Polymerase chain reaction, PFT= Pulmonary function test.
References
- ↑ Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
- ↑ Kubaisi B, Abu Samra K, Foster CS (2016). "Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations". Intractable Rare Dis Res. 5 (2): 61–9. doi:10.5582/irdr.2016.01014. PMC 4869584. PMID 27195187.
- ↑ Keogh KA, Specks U (April 2006). "Churg-Strauss syndrome". Semin Respir Crit Care Med. 27 (2): 148–57. doi:10.1055/s-2006-939518. PMID 16612766.
- ↑ Keasberry J, Frazier J, Isbel NM, Van Eps CL, Oliver K, Mudge DW (2013). "Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report". J Med Case Rep. 7: 20. doi:10.1186/1752-1947-7-20. PMC 3565908. PMID 23316942.
- ↑ McAdoo SP, Pusey CD (July 2017). "Anti-Glomerular Basement Membrane Disease". Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMID 28515156.
- ↑ Ferri C, Mascia MT (January 2006). "Cryoglobulinemic vasculitis". Curr Opin Rheumatol. 18 (1): 54–63. PMID 16344620.
- ↑ Guo QY, Wu M, Wang YW, Sun GD (2017). "Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report". Exp Ther Med. 14 (2): 1395–1398. doi:10.3892/etm.2017.4671. PMC 5525644. PMID 28810602.
- ↑ Farhadian JA, Castilla C, Shvartsbeyn M, Meehan SA, Neimann A, Pomeranz MK (December 2015). "IgA vasculitis (Henoch-Schönlein purpura)". Dermatol. Online J. 21 (12). PMID 26990342.
- ↑ Buck A, Christensen J, McCarty M (2012). "Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review". J Clin Aesthet Dermatol. 5 (1): 36–46. PMC 3277093. PMID 22328958.
- ↑ Sise MJ (February 2014). "Acute mesenteric ischemia". Surg. Clin. North Am. 94 (1): 165–81. doi:10.1016/j.suc.2013.10.012. PMID 24267504.
- ↑ McDonald JR (2009). "Acute infective endocarditis". Infect Dis Clin North Am. 23 (3): 643–64. doi:10.1016/j.idc.2009.04.013. PMC 2726828. PMID 19665088.
- ↑ Einhorn J, Levis JT (2015). "Dermatologic Diagnosis: Leukocytoclastic Vasculitis". Perm J. 19 (3): 77–8. doi:10.7812/TPP/15-001. PMC 4500485. PMID 26176572.
- ↑ Margo CE, Goldman DR (2008). "Langerhans cell histiocytosis". Surv Ophthalmol. 53 (4): 332–58. doi:10.1016/j.survophthal.2008.04.007. PMID 18572052.
- ↑ Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008). "Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship". Mayo Clin Proc. 83 (5): 584–94. doi:10.4065/83.5.584. PMC 2718421. PMID 18452692.
- ↑ Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
- ↑ Parambil JG, Savci CD, Tazelaar HD, Ryu JH (April 2005). "Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy". Chest. 127 (4): 1178–83. doi:10.1378/chest.127.4.1178. PMID 15821192.
- ↑ VanDeVoorde RG (January 2015). "Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis". Pediatr Rev. 36 (1): 3–12, quiz 13. doi:10.1542/pir.36-1-3. PMID 25554106.
- ↑ Corrigan JJ, Boineau FG (November 2001). "Hemolytic-uremic syndrome". Pediatr Rev. 22 (11): 365–9. PMID 11691946.
- ↑ Byrd JC, Stilgenbauer S, Flinn IW (2004). "Chronic lymphocytic leukemia". Hematology Am Soc Hematol Educ Program: 163–83. doi:10.1182/asheducation-2004.1.163. PMID 15561682.
- ↑ Michels TC, Petersen KE (March 2017). "Multiple Myeloma: Diagnosis and Treatment". Am Fam Physician. 95 (6): 373–383. PMID 28318212.
- ↑ Klion A (2009). "Hypereosinophilic syndrome: current approach to diagnosis and treatment". Annu. Rev. Med. 60: 293–306. doi:10.1146/annurev.med.60.062107.090340. PMID 19630574.
- ↑ Shankland KR, Armitage JO, Hancock BW (September 2012). "Non-Hodgkin lymphoma". Lancet. 380 (9844): 848–57. doi:10.1016/S0140-6736(12)60605-9. PMID 22835603.
- ↑ Lin RY (January 1986). "Serum sickness syndrome". Am Fam Physician. 33 (1): 157–62. PMID 2867672.
- ↑ Venugopal A (2014). "Disseminated intravascular coagulation". Indian J Anaesth. 58 (5): 603–8. doi:10.4103/0019-5049.144666. PMC 4260307. PMID 25535423.
- ↑ Nomura S (2016). "Advances in Diagnosis and Treatments for Immune Thrombocytopenia". Clin Med Insights Blood Disord. 9: 15–22. doi:10.4137/CMBD.S39643. PMC 4948655. PMID 27441004.
- ↑ Chiarchiaro J, Chen BB, Gibson KF (2016). "New molecular targets for the treatment of sarcoidosis". Curr Opin Pulm Med. 22 (5): 515–21. doi:10.1097/MCP.0000000000000304. PMC 5152532. PMID 27454074.
- ↑ Murdoch DR (January 2003). "Diagnosis of Legionella infection". Clin. Infect. Dis. 36 (1): 64–9. doi:10.1086/345529. PMID 12491204.
- ↑ Tsokos, George C. (2011). "Systemic Lupus Erythematosus". New England Journal of Medicine. 365 (22): 2110–2121. doi:10.1056/NEJMra1100359. ISSN 0028-4793.
- ↑ Scott JT (1991). "The gold standard in rheumatoid arthritis". J R Soc Med. 84 (9): 513–4. PMC 1293405. PMID 1682491.
- ↑ Emmungil H, Aydın SZ (2015). "Relapsing polychondritis". Eur J Rheumatol. 2 (4): 155–159. doi:10.5152/eurjrheum.2015.0036. PMC 5047229. PMID 27708954.